
Opinion|Videos|October 7, 2023
AUGMENT: Lenalidomide plus Rituximab in R/R Follicular Lymphoma
Experts review data updates from the AUGMENT trial and discuss potential clinical implications of these study findings.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts Topical Gel sNDA for Superficial Basal Cell Carcinoma
2
Advances in Immunotherapy for Breast Cancer
3
Phase 2b Prostate Cancer Study Receives FDA Clearance in High-Risk Groups
4
Tandem 2026: Key Advances in Cellular Therapy and Transplantation
5







































